(c)
Chile Group, at any time on a consolidated basis, will not incur any Financial Indebtedness
in an aggregate principal amount at any one time in excess of NOK 50,000,000, other than
Qualified Securitization Financings; and
(d)
Restrictions on cash: to the extent it can lawfully do so and without breaching any
directors' duties, regulatory requirements or any agreement binding on it, Issuer shall ensure
that the Pharmaq Chile Group will not own or hold cash or cash equivalents in excess of the
required cash in order to maintain ordinaiy business operations the next 12 months,
